Quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human plasma by liquid chromatography–tandem mass spectrometry following automated solid-phase extraction

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences - Tập 788 - Trang 377-386 - 2003
A Schuster1, S Burzawa2, M Jemal1, E Loizillon2, P Couerbe2, D Whigan1
1Drug Disposition and Bioanalytical Sciences, Bristol-Myers Squibb Pharmaceutical Research Institute, One Squibb Drive, New Brunswick, NJ 08903, USA
2Bioanalytical Department, Bristol-Myers Squibb Pharmaceutical Research Institute, F-44600 St-Nazaire, France

Tài liệu tham khảo

Gong, 2000, Antimicrob. Agents Chemother., 44, 2319, 10.1128/AAC.44.9.2319-2326.2000 Drusano, 2001, J. Infect. Dis., 183, 1126, 10.1086/319281 Knebel, 1995, J. Mass Spectrom., 30, 1149, 10.1002/jms.1190300812 Fitzsimmons, 1997, Drug Metab. Dispos., 25, 256 Shah, 1991, Eur. J. Drug Metab. Pharmacokinet., 16, 249, 10.1007/BF03189968 Personal communication.
Thông tin
Thông tin xuất bản

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Tập 788

377-386

Thông tin tác giả